DK0863752T3 - Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion. - Google Patents

Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.

Info

Publication number: DK0863752T3
Authority: DK; Denmark
Prior art keywords: terbinafine; medicament; pylori infection; manufacture; treatment
Prior art date: 1995-07-06

Application number

DK96924889T

Other languages

Danish (da)

English (en)

Inventor

Ivan James Dalton Lindley

Neil Stewart Ryder

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-06

Filing date

1996-07-05

Publication date

2003-04-22

1996-07-05 Application filed by Novartis Ag filed Critical Novartis Ag

2003-04-22 Application granted granted Critical

2003-04-22 Publication of DK0863752T3 publication Critical patent/DK0863752T3/da

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
206010019375 Helicobacter infections Diseases 0.000 title 1
150000003973 alkyl amines Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title 1
229960002722 terbinafine Drugs 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
150000003839 salts Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Nutrition Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)

DK96924889T 1995-07-06 1996-07-05 Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion. DK0863752T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9513750.1A GB9513750D0 (en)	1995-07-06	1995-07-06	Use of allylamines
PCT/EP1996/002970 WO1997002026A1 (en)	1995-07-06	1996-07-05	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases

Publications (1)

Publication Number	Publication Date
DK0863752T3 true DK0863752T3 (da)	2003-04-22

Family

ID=10777201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96924889T DK0863752T3 (da)	1995-07-06	1996-07-05	Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion.

Country Status (26)

Country	Link
US (1)	US5935998A (cs)
EP (1)	EP0863752B1 (cs)
JP (1)	JP3680950B2 (cs)
KR (1)	KR100425401B1 (cs)
CN (1)	CN1204881C (cs)
AT (1)	ATE232723T1 (cs)
AU (1)	AU715270B2 (cs)
CA (1)	CA2219678C (cs)
CY (1)	CY2465B1 (cs)
CZ (1)	CZ289440B6 (cs)
DE (1)	DE69626301T2 (cs)
DK (1)	DK0863752T3 (cs)
ES (1)	ES2192608T3 (cs)
GB (1)	GB9513750D0 (cs)
HU (1)	HU224311B1 (cs)
IL (1)	IL122853A (cs)
MX (1)	MX9710093A (cs)
MY (1)	MY132436A (cs)
NO (1)	NO317496B1 (cs)
PL (1)	PL187704B1 (cs)
RU (1)	RU2193402C2 (cs)
SI (1)	SI0863752T1 (cs)
SK (1)	SK282874B6 (cs)
TW (1)	TW522011B (cs)
WO (1)	WO1997002026A1 (cs)
ZA (1)	ZA965749B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001315D0 (en) *	2000-01-20	2000-03-08	Novartis Ag	Organic compounds
US7244703B2 (en) *	2001-06-22	2007-07-17	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for peptide treatment
KR20030066186A (ko) *	2002-02-05	2003-08-09	한솔케미언스 주식회사	(ｅ)-터비나핀 또는 이의 염산염의 제조방법
RU2236228C2 (ru) *	2002-11-14	2004-09-20	Российский государственный медицинский университет	Способ профилактики рецидивов кровотечений из язв и эрозий при язвенной болезни желудка и двенадцатиперстной кишки, ассоциированной с helicobacter pylori
JP2007513199A (ja)	2003-12-08	2007-05-24	ベントレーファーマスーティカルス，インコーポレイテッド	インスリン治療のための薬学的組成物及び方法
RU2269353C1 (ru) *	2004-06-10	2006-02-10	ФГУП Государственный научно-исследовательский институт особо чистых биопрепаратов	Способ лечения malt-лимфом желудка
RU2449805C1 (ru)	2011-01-27	2012-05-10	Общество С Ограниченной Ответственностью "Гармония"	Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2716943C2 (de) *	1976-04-28	1986-08-14	Sandoz-Patent-GmbH, 7850 Lörrach	N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE2862103D1 (en) *	1977-08-19	1982-11-18	Sandoz Ag	Propenyl amines, processes for their production and pharmaceutical compositions containing them
DE3020113A1 (de) *	1979-06-08	1980-12-18	Sandoz Ag	2-(1-naphthyl)piperidin-derivat, dessen herstellung sowie die verwendung als antimykotika
US5132459A (en) *	1979-08-22	1992-07-21	Sandoz Ltd.	Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CY1410A (en) *	1979-08-22	1988-04-22	Sandoz Ag	Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
US4894375A (en) *	1986-09-29	1990-01-16	Merck & Co., Inc.	Method of controlling mycotic infections and compositions therefor
CA2020888A1 (en) *	1989-07-27	1991-01-28	Philippe Guerry	Substituted aminoalkoxybenzene derivatives
US5200195A (en) *	1991-12-06	1993-04-06	Alza Corporation	Process for improving dosage form delivery kinetics
DE4317449A1 (de) *	1993-05-19	1994-11-24	Asche Ag	Arzneimittel zur Behandlung von Erkrankungen des Magen-Darm-Traktes

1995
- 1995-07-06 GB GBGB9513750.1A patent/GB9513750D0/en active Pending
1996
- 1996-07-05 AU AU65195/96A patent/AU715270B2/en not_active Ceased
- 1996-07-05 JP JP50483397A patent/JP3680950B2/ja not_active Expired - Fee Related
- 1996-07-05 AT AT96924889T patent/ATE232723T1/de not_active IP Right Cessation
- 1996-07-05 SI SI9630594T patent/SI0863752T1/xx unknown
- 1996-07-05 ZA ZA9605749A patent/ZA965749B/xx unknown
- 1996-07-05 IL IL12285396A patent/IL122853A/en not_active IP Right Cessation
- 1996-07-05 CA CA002219678A patent/CA2219678C/en not_active Expired - Fee Related
- 1996-07-05 WO PCT/EP1996/002970 patent/WO1997002026A1/en not_active Ceased
- 1996-07-05 RU RU98102187/14A patent/RU2193402C2/ru not_active IP Right Cessation
- 1996-07-05 EP EP96924889A patent/EP0863752B1/en not_active Expired - Lifetime
- 1996-07-05 SK SK6-98A patent/SK282874B6/sk not_active IP Right Cessation
- 1996-07-05 ES ES96924889T patent/ES2192608T3/es not_active Expired - Lifetime
- 1996-07-05 DE DE69626301T patent/DE69626301T2/de not_active Expired - Lifetime
- 1996-07-05 KR KR10-1998-0700023A patent/KR100425401B1/ko not_active Expired - Fee Related
- 1996-07-05 CN CNB96195289XA patent/CN1204881C/zh not_active Expired - Fee Related
- 1996-07-05 MY MYPI96002783A patent/MY132436A/en unknown
- 1996-07-05 DK DK96924889T patent/DK0863752T3/da active
- 1996-07-05 CZ CZ199817A patent/CZ289440B6/cs not_active IP Right Cessation
- 1996-07-05 US US08/981,324 patent/US5935998A/en not_active Expired - Fee Related
- 1996-07-05 HU HU9802929A patent/HU224311B1/hu not_active IP Right Cessation
- 1996-07-05 PL PL96323305A patent/PL187704B1/pl not_active IP Right Cessation
- 1996-07-05 MX MX9710093A patent/MX9710093A/es not_active IP Right Cessation
- 1996-07-06 TW TW085108161A patent/TW522011B/zh not_active IP Right Cessation
1997
- 1997-12-09 NO NO19975790A patent/NO317496B1/no not_active IP Right Cessation
2004
- 2004-07-02 CY CY0400055A patent/CY2465B1/xx unknown

Also Published As

Publication number	Publication date
KR100425401B1 (ko)	2004-07-16
PL187704B1 (pl)	2004-09-30
GB9513750D0 (en)	1995-09-06
EP0863752A1 (en)	1998-09-16
SK282874B6 (sk)	2003-01-09
KR19990028725A (ko)	1999-04-15
CY2465B1 (en)	2005-06-03
MY132436A (en)	2007-10-31
ZA965749B (en)	1998-01-05
HK1011527A1 (en)	1999-07-16
JPH11508580A (ja)	1999-07-27
HU224311B1 (hu)	2005-07-28
CZ289440B6 (cs)	2002-01-16
PL323305A1 (en)	1998-03-16
WO1997002026A1 (en)	1997-01-23
AU715270B2 (en)	2000-01-20
AU6519596A (en)	1997-02-05
IL122853A (en)	2001-04-30
NO317496B1 (no)	2004-11-08
CZ1798A3 (cs)	1998-03-18
CA2219678A1 (en)	1997-01-23
NO975790L (no)	1997-12-09
DE69626301T2 (de)	2003-10-16
NO975790D0 (no)	1997-12-09
US5935998A (en)	1999-08-10
HUP9802929A2 (hu)	1999-09-28
DE69626301D1 (de)	2003-03-27
ATE232723T1 (de)	2003-03-15
SI0863752T1 (en)	2003-06-30
CN1204881C (zh)	2005-06-08
RU2193402C2 (ru)	2002-11-27
TW522011B (en)	2003-03-01
JP3680950B2 (ja)	2005-08-10
IL122853A0 (en)	1998-08-16
EP0863752B1 (en)	2003-02-19
CN1189775A (zh)	1998-08-05
SK698A3 (en)	1998-05-06
MX9710093A (es)	1998-03-31
HUP9802929A3 (en)	1999-10-28
CA2219678C (en)	2006-10-10
ES2192608T3 (es)	2003-10-16

Publication	Publication Date	Title
NO960067L (no)	1996-01-05	Nytt farmasöytisk preparat
TR200000129T2 (tr)	2000-07-21	Yepyeni spiroazabisiklik heterosiklik bileşikler.
BR9611175B1 (pt)	2009-01-13	compostos e composiÇÕes farmacÊuticas.
DE122010000050I1 (de)	2011-05-05	Sublinguales oder bukkales arzneimittel
ATE248837T1 (de)	2003-09-15	Chinuclidin-acrylamide
ATE269846T1 (de)	2004-07-15	N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
DK0733046T3 (da)	2001-09-03	Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
AU2672995A (en)	1995-12-21	{a}-annelated pyrrole derivatives and pharmaceutical uses thereof
SE9401728D0 (sv)	1994-05-18	New compounds II
DK0680326T3 (da)	1997-06-23	Farmaceutisk formulering af nikotinafhængighed.
BR0113590A (pt)	2003-07-22	7-oxo-piridopirimidinas
ATE360428T1 (de)	2007-05-15	Analgetisches arzneimittel
GEP20043227B (en)	2004-04-26	5HT1 Antagonists for Antidepressant Therapy
SI0863752T1 (en)	2003-06-30	Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
BR9506956A (pt)	1997-09-16	Composição farmacêutica antitussígena
SE9302218D0 (sv)	1993-06-28	New use
BG105434A (bg)	2001-12-29	Сертралинов орален концентрат
NO973340L (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
BR0211223A (pt)	2004-08-10	Derivados de 4-aminociclohexanol substituìdos
SE0004827D0 (sv)	2000-12-22	Therapeutic compounds
NO973242L (no)	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
DK0766695T3 (da)	1999-02-15	Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme
KR960700053A (ko)	1996-01-19	방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
MX9803271A (es)	1998-09-30	Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.